United States · Biotechnology startup
United States · GentiBio
GentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapies (EngTregs) to address Type 1 diabetes and other i
Funding reportedLast round: Series A
About GentiBio
GentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapies (EngTregs) to address Type 1 diabetes and other i
mmune-related diseases. The company aims to improve autoimmune and acute inflammatory conditions by suppressing inflammation in a targeted manner while promoting tissue healing and restoring immune balance. Headquartered in Cambridge, Massachusetts, GentiBio utilizes a proprietary modular engineering platform to create stable and scalable EngTregs. This platform combines patient-derived and donor-derived technologies to enhance immune tolerance. The company's therapeutic pipeline includes a specific candidate named GNTI-122, with a primary focus on curing Type 1 diabetes and addressing conditions such as Inflammatory Bowel Disease, Systemic Lupus Erythematosus, and Multiple Sclerosis. GentiBio has raised $177 million from notable investors, including Bristol-Myers Squibb and Novartis, to support its mission and future collaborations.
What company datasets say GentiBio raised
Funding, as reported
Founders and team
From GentiBio's own website: 1 on the team.
- Nathan ZammitPrincipal Scientist
On 2 portfolio pages
Investors who name them
Each firm lists GentiBio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
b2b
Built with from their website
Google CloudGoogle Cloud HostingMicrosoft ExchangeMicrosoft 365 Apps & ServicesMicrosoft Exchange OnlineMicrosoft 365Google Cloud DNSOutlookMicrosoft Email Providers
- Sector
- Biotechnology
- Industry code
- NAICS 541714
- Region
- Massachusetts
- Revenue
- $2.5M a year, as listed
- Full record
- Every detail in the company directory
Biotechnology in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put GentiBio in front of investors. Or tell us what we have wrong.